Full-Time

Director – Professional Engagements and Partnerships

Dermatology

Confirmed live in the last 24 hours

Takeda

Takeda

10,001+ employees

Global biopharmaceutical firm focused on R&D

Compensation Overview

$174.5k - $274.2k/yr

+ Short-term Incentives + Long-term Incentives

Senior, Expert

Boston, MA, USA

Category
Project Management
Strategy Development
Business Development
Business & Strategy
Required Skills
Sales
Branding/Brand Strategy
Requirements
  • Bachelor’s degree required.
  • 10+ years of marketing, sales, and/or related commercial function in the pharmaceutical industry required with a minimum of 4 years in commercial pharmaceutical marketing
  • Excel at anticipating and adapting to fast-changing market dynamics.
  • Experience developing engagement plans for KOLs / KOL management and ability to comfortably liaise with these customers.
  • Strong leadership skills with an ability to set direction, generate commitment, identify, and resolve issues, and evaluate risk. Equally important is the ability to collaborate and work effectively with cross-functional teams with a proven ability to influence without authority.
  • Analytical, problem solving, and strategic thinking skills.
  • Financial management and budgeting capabilities.
  • Willingness to travel to various internal and external meetings and conferences that could include overnight stays ranging from one to several nights. Some weekend and/or international travel may be required.
Responsibilities
  • Establish and lead a centralized professional engagement, strategy and execution function for the Dermatology Franchise. Develop the professional engagement strategy and oversee execution for a new product launch, manage internal and external stakeholders, and lead cross-functional teams to help Takeda better serve patients.
  • Develop the professional education strategy and manage medical education marketing initiatives for a new product launch. This includes overseeing the creation, implementation, and accountability of interactions and feedback with external experts. Collaboratively lead the development and execution of brand strategies and innovative tactics designed to drive sales, expand market share, and enhance profitability.
  • Provide leadership and oversight to a team that facilitates strategy development of professional engagement and education, congress strategy and execution, and sponsorship process execution. Build and enable the development of a team of thought leader liaisons to foster a positive culture within the team and with cross-functional partners.
  • Identify, cultivate, and maintain long-standing relationships with national and regional key opinion leaders (KOLs) and advisors and develop engagement strategy designed to inform appropriate KOL partnership to better serve patients and meet identified business needs; this may include engaging with KOLs to provide training on disease state, product and market dynamics for internal teams and training on disease state and product education for external healthcare professionals (HCPs)/Ambassadors.
  • Monitor KOL insights regarding market dynamics, disease state, current and future treatment patterns, and competitive landscape. Distil these findings and perspectives into insights to share in a structured way with the broader team to inform brand plan and tactical execution. To enable insight gathering and education efforts, manage the use of an HCP engagement tracking platform to identify appropriate HCP for specific fee-for-service activities based on qualifications and expertise directly related to the identified need.
  • Based on insight/trend identification, lead the development and implementation of regional strategies, tactics, and/or training solutions in collaboration with franchise, marketing, training, and cross-functional field counterparts. Ensure content, disease state and product messaging, resources, platforms, and execution are aligned with franchise strategy and strategic imperatives for that audience.
  • Define and execute congress strategy for local and regional congresses in alignment with brand priorities.
  • Enable the innovation of commercial ways of working by leveraging technology, customer insights, field observations, and continued education. Engage with internal and external partners to seek insights, best practices, and synergistic opportunities.
  • Liaise with legal, regulatory, and ethics and compliance to ensure all activities are compliant with policies and regulations.
  • Assume specific budget management/accountability for Professional Engagement projects and Annual Plan Commitments. Manage spending against budget/forecast and perform all monthly accruals and reporting requirements. Proactively identify trends and insights to optimize spend and as appropriate, program performance.
Desired Qualifications
  • Advanced degree (MBA, MA/MS, PharmD, etc.)
  • Client/customer relationship management experience
  • Commercial pharma experience in Psoriasis, including an in-depth understanding of the disease state, treatment paradigms, and future trends
  • New product launch experience

Takeda Pharmaceutical Company Limited is a global biopharmaceutical firm that focuses on developing and delivering treatments and vaccines for patients. The company invests heavily in research and development to create new molecular entities (NMEs) and has a pipeline of 11 NMEs, with plans for up to 15 product launches by FY2024. Takeda collaborates with around 41,000 suppliers worldwide to ensure the production and distribution of its medicines. Unlike many competitors, Takeda emphasizes patient-centric values, placing the needs of patients at the core of its operations. Additionally, the company is committed to environmental sustainability, recognizing the connection between environmental health and human health. Takeda's goal is to provide life-changing therapies while also addressing environmental risks that could affect public health.

Company Size

10,001+

Company Stage

IPO

Headquarters

Tokyo, Japan

Founded

1781

Simplify Jobs

Simplify's Take

What believers are saying

  • Takeda's collaboration with BridGene is worth up to $770 million.
  • The company is expanding its market presence in emerging Asian economies.
  • Takeda's focus on personalized medicine aligns with industry trends.

What critics are saying

  • Antitrust litigation over Amitiza could harm Takeda's reputation and finances.
  • A data breach incident poses significant cybersecurity and legal risks.
  • The telehealth market's rapid changes may affect Takeda's investment in American Well.

What makes Takeda unique

  • Takeda has a 240-year history in the biopharmaceutical industry.
  • The company emphasizes patient-centric values in its operations.
  • Takeda has a robust pipeline with 11 NMEs and aims for 15 launches by FY2024.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Wellness Program

Tuition Reimbursement

Company News

ETF Daily News
May 11th, 2025
Tudor Investment Corp ET AL Decreases Stock Holdings in American Well Co. (NYSE:AMWL)

Takeda Pharmaceutical Co. Ltd. acquired a new stake in American Well in the fourth quarter worth about $564,000.

CyberNews
Apr 15th, 2025
Hackers want $75,000 for data allegedly stolen from Takeda

A new account on an illicit forum bearing the moniker "beltway" claims that in April 2025, it exported around two million rows of user information from Takeda.com.

MLex
Mar 4th, 2025
Meijer seeks quick appeal in US antitrust case against Takeda

( March 4, 2025, 17:06 GMT | Official Statement) - MLex Summary: Meijer asked a US federal judge for leave to immediately appeal an order that sent its antitrust case against Takeda Pharmaceuticals over the drug Amitiza to arbitration.

BioSpace
Mar 3rd, 2025
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial

Protagonist, which will receive a $25 million milestone from Takeda thanks to the positive results, plans to submit the findings to regulators.

Access Health
Mar 3rd, 2025
Strengthening Access to Medicines in Southeast Asia: Highlights from Southeast Asia Access to Medicine (SEA AtM) Summit

ACCESS Health International, in collaboration with AVPN, SingHealth Duke-NUS Global Health Institute, and Takeda, successfully co-hosted the first Southeast Asia Access to Medicine (SEA AtM) Summit in Bangkok.